MariMed COO exercises RSUs, updates holdings
MariMed Inc. reports that COO Timothy Shaw exercised 42,656 RSUs into common stock and had 14,781 shares withheld to satisfy tax obligations related to the vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MariMed Inc. reports that COO Timothy Shaw exercised 42,656 RSUs into common stock and had 14,781 shares withheld to satisfy tax obligations related to the vesting. After these transactions, he holds 9,412,123 shares directly and 127,969 RSUs, plus 2,000,000 shares held in an irrevocable family trust for his children, for which he disclaims beneficial ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (RSU) F1, F4 | 42,656 | $0.00 | $0.00 |
| Exercise | Common stock F1 | 42,656 | $0.00 | $0.00 |
| Tax Withholding | Common stock F2 | 14,781 | $0.0662 | $978.50 |
| holding | Common stock F3 | -- | -- | -- |
Footnotes (4)
- F1. RSUs convert to shares of common stock on a one-for-one basis.
- F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
- F3. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in three equal installments on each of October 15, 2026, January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Key Figures
Key Terms
Restricted Stock Units (RSU) financial
tax withholding obligations financial
irrevocable trust financial
beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider equity transactions did MariMed (MRMD) COO Timothy Shaw report?
What is the RSU vesting schedule disclosed for MariMed (MRMD) COO Timothy Shaw?
AI-generated analysis. How Rhea-AI works. Not financial advice.